Skip to Main Content
Full Service CRO
Full Service CRO
Clinical Analytics
Site Network
Consulting
Development Phase
Preclinical Preclinical and clinical research planning helps you bring forward the best emerging science to improve cancer diagnosis and treatment.
Early Phase Research Catalyst Oncology, an oncology clinical research organization, works with innovative biotechs on a range of early phase study designs and therapies.
Late Phase Research Catalyst Oncology helps move oncology therapies through the complex and dynamic clinical trial environment with workable solutions, best-in-class technologies, and a data-centric approach.
Case Study
Immuno-Oncology
Helping to bring immunotherapies to cancer patients in need
Read more
Insights
Contact Us
Full Service CRO
Full Service CRO
Clinical Analytics
Site Network
Consulting
Development Phase
PreclinicalPreclinical and clinical research planning helps you bring forward the best emerging science to improve cancer diagnosis and treatment.
Early Phase ResearchCatalyst Oncology, an oncology clinical research organization, works with innovative biotechs on a range of early phase study designs and therapies.
Late Phase ResearchCatalyst Oncology helps move oncology therapies through the complex and dynamic clinical trial environment with workable solutions, best-in-class technologies, and a data-centric approach.
Case Study
Immuno-Oncology
Helping to bring immunotherapies to cancer patients in need
Read more
Insights
Contact Us

Traditional Site Networks Are Broken

Adam Coleman
Louise Scott PhD
August 28, 2024

Building Real Site Relationships to Facilitate the Success of Early Phase Oncology Trials

Oncology clinical trials are complex. Catalyst Oncology helps identify high-performing, high-quality trial sites. Our flexible and tailored approach helps find sites with the resources, infrastructure, and knowledge to meet the needs of today’s clinical trials.

Successful oncology site networks are being redefined based on quality relationships between sites, contract research organizations (CROs), and Sponsors.

Read the *International Clinical Trials article published in the Summer 2024 issue.

*International Clinical Trials, August 2024, pages 39-42. © Samedan Ltd

Article
Adam Coleman
Associate Director, Feasibility/Site Network Development and Oversight
Louise Scott PhD
Director, Oncology Drug Development

Recently Published

View All
Single confident smiling woman in blue shirt with folded hands at desk in a bright, sunlight filled office Case Study Executive Safety Support Long-term global pharmacovigilance assistance Catalyst Oncology provided a range of pharmacovigilance services for an active Read Now
Office conference table during meeting with partial views of the laptops. Case Study Safe and Sound Supporting pharmacovigilance during global expansions Catalyst Oncology contracted for studies across several indications and countries. Read Now
Multicolored pills on white background. Blog FDA Finalizes Project Optimus Guidance for Dosing and Expectations for First-in-Human Oncology Trials The past 18 months have been Read Now
View All